Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Galactose-3-O-sulfotransferase 3 is an enzyme encoded by the GAL3ST3 gene in humans, responsible for transferring a sulfate group to the 3' position of galactose within N-glycans and core2-branched O-glycans[1][2][7]. This modification alters the physical and biological properties of glycoproteins and glycolipids, influencing cellular processes such as cell-cell recognition and signal transduction[1][2]. GAL3ST3 belongs to the family of sulfotransferases, and while its specific physiological and pathological roles in human disease are not well defined in current literature, sulfotransferase-mediated sulfonation is known to impact immune function, development, and potentially disease progression through modification of glycan structures on cell surfaces and secreted molecules[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Galactose-3-O-sulfotransferase 3 (GAL3ST3).